To study Memantine as an add-on drug to Escitalopram for Geriatric depression: A double-blind trial
Not Applicable
- Conditions
- Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
- Registration Number
- CTRI/2024/07/069806
- Lead Sponsor
- Dayanand Medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.The patients with a diagnosis of Major depressive disorder according to DSM-5 criteria presenting to Department of Psychiatry,DMC&H, Ludhiana
2.Age group 60-99 years
3.Score of more than or equal to 16 on the 24-item Hamilton Rating Scale for Depression (HAM-D)
4.Score of more than 5 on Geriatric Depression Scale
5.Patients who have given consent for the study
Exclusion Criteria
1.History of any other major psychiatric disorder
2.Recent or current unstable medical or neurological disorder
3.Diagnosis of moderate/severe cognitive impairment and patients with dementia (Dementia screening by Clinical Dementia Rating Score of 0.5)
4.Known allergic reaction to Escitalopram or Memantine
5.Patients who have not given consent for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method